A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate ) for folliculogenesis in routine in vitro fertilization patients
- 1 September 1991
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 56 (3), 509-514
- https://doi.org/10.1016/s0015-0282(16)54550-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Controlled Study of Luteinizing Hormone–Releasing Hormone Agonist (Buserelin) for the Induction of Folliculogenesis before in Vitro FertilizationNew England Journal of Medicine, 1989
- Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrievalFertility and Sterility, 1989
- Utilization of GnRH agonists for poor responders in an IVF programmeHuman Reproduction, 1989
- Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFTHuman Reproduction, 1988
- Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormoneBMJ, 1988
- An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analogFertility and Sterility, 1988
- An Analysis of Plasma Estradiol Concentrations during Clomiphene Citrate-Human Menopausal Gonadotropin Stimulation in anin VitroFertilization-Embryo Transfer ProgramJournal of Clinical Endocrinology & Metabolism, 1986
- Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppressionFertility and Sterility, 1986
- INDUCTION OF OVULATION FOR IN-VITRO FERTILISATION USING BUSERELIN AND GONADOTROPINSThe Lancet, 1984
- Pregnancies in Humans by Fertilization in Vitro and Embryo Transfer in the Controlled Ovulatory CycleScience, 1981